Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Headquarters
Chungjeong-ro Seodaemun-gu Seoul
Seoul; Seoul; Map
Postal Code: 120756
Tel: 02-2194-
Fax: 02-2194-
Website: http://www.ckdbio.com

Full name: Ckd Bio Corp.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 1650186
ISIN: KR7063160006
Incorporation Date: 12-Nov-01

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Medeicinal supplies, material madicine

Company Description

Ckd Bio Corp. is engaged in manufacturing and distribution of pharmaceutical materials and medicines. The company distribute its products in markets including Asia, Africa, Middle East, Japan. Europe and America. Ckd Bio Corp. is based in Seoul with operating plants in Ansan and Chonan, South Korea. The company was incorporated in 2001 formerly known as Chong Kun Dang Pharmaceutical Co., Ltd.

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 22,200.00
Volume 6,913
Turnover 153,641,425
Index
Market Korea Stock Exchange
Ticker 63160
Market Cap Market Cap 116,094,656
52 Week High 32,300.00
52 Week Low 20,150.00
Price to Earnings (P/E) 17.45
Earnings per Share (EPS) 1272.23
Dividend Yield
Bookvalue 127,326,674
Enterprise Value 114,253,113
Quote updated on December 02, 2016
Note: data in KRW Thousands.

Key Executives

Non-Executive Independent Director
More

Ownership Details

Lee,Jang Han
19%
Other

Key Stats

Select Items to chart them. 2016 H1
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss)
Total assets 175,414,143
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: NICE Information Service , EMIS Company Database.

Financials

Competitors - South Korea

KRW | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2015
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest